"Designing Growth Strategies is in our DNA"

North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Monoclonal Antibodies, Antineoplastic, Hedgehog Pathway Inhibitors, and Others), By Route of Administration (Oral, Topical, and Parenteral); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Forecast, 2021-2028

Last Updated: January 27, 2025 | Format: PDF | Report ID: FBI106348

 


North America Basal Cell and Squamous Cell Carcinoma Therapeutics Market

  • 2017-2028
  • 2020
  • 2017-2019
  • 122
Multi-report Purchase Plan
    A Customized Plan Will be Created Based on the number of reports you wish to purchase